Fabio
5.0 KiB
5.0 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Office-based buprenorphine treatment; Board of Medicine to amend regulations. | Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care and is identical to SB 641. | us/states/va | Virginia General Assembly | 2026 | HB 712 | Virginia HB 712 (2026) |
|
enacted |
|
3 | 26 | 6 | 2026-01-13 | 2026-04-06 | openstates | ocd-bill/1e18e721-8ed5-4cbb-a16b-b6ab7a02b07b | https://lis.virginia.gov/bill-details/20261/HB712 | 3ad45904670821cc302ae24be0285e40d5a647a96861f2bed2672c708f6b81f4 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia HB 712 (2026) — Office-based buprenorphine treatment; Board of Medicine to amend regulations.
Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care and is identical to SB 641.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- H VOTE: — 99–0 (pass) · lower
- Reported from Health and Human Services — 22–0 (pass) · lower
- Constitutional reading dispensed (on 2nd reading) — 40–0 (pass) · upper
- Reported from Education and Health — 13–0 (pass) · upper
- Passage R — 38–0 (pass) · upper
- Subcommittee recommends reporting — 10–0 (pass) · lower
Sponsors
- H. Otto Wachsmann, Jr. — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2026-01-13 Prefiled and ordered printed; Offered 01-14-2026 26104755D
filing, introduction - 2026-01-13 Referred to Committee on Health and Human Services
referral-committee - 2026-01-16 Fiscal Impact Statement from Department of Planning and Budget (HB712)
- 2026-01-21 Assigned sub: Health Professions
referral-committee - 2026-01-22 Subcommittee recommends reporting (10-Y 0-N)
- 2026-01-27 Reported from Health and Human Services (22-Y 0-N)
committee-passage - 2026-01-29 Read first time
reading-1 - 2026-01-30 Read second time and engrossed
reading-2 - 2026-02-02 Read third time and passed House (99-Y 0-N 0-A)
passage, reading-3 - 2026-02-03 Constitutional reading dispensed (on 1st reading)
- 2026-02-03 Referred to Committee on Education and Health
referral-committee - 2026-02-19 Reported from Education and Health (13-Y 0-N)
committee-passage - 2026-02-20 Rules suspended
- 2026-02-20 Constitutional reading dispensed (on 2nd reading) (40-Y 0-N 0-A)
- 2026-02-20 Passed by for the day (Voice Vote)
- 2026-02-23 Read third time
reading-3 - 2026-02-23 Passed Senate (38-Y 0-N 0-A)
passage - 2026-02-25 Enrolled
enrolled - 2026-02-25 Bill text as passed House and Senate (HB712ER)
passage - 2026-02-25 Signed by Speaker
passage - 2026-02-25 Signed by President
passage - 2026-02-26 Fiscal Impact Statement from Department of Planning and Budget (HB712)
- 2026-03-10 Enrolled Bill communicated to Governor on March 10, 2026
enrolled, executive-receipt - 2026-03-10 Governor's Action Deadline 11:59 p.m., April 13, 2026
executive-receipt - 2026-04-06 Approved by Governor-Chapter 207 (effective 7/1/2026)
executive-signature - 2026-04-06 Acts of Assembly Chapter text (CHAP0207)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/1e18e721-8ed5-4cbb-a16b-b6ab7a02b07b. Confidence: reported (aggregated from official Virginia legislature records).